Krystle Q Pham, MD
Obstetrics/Gynecology · La Jolla
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 4 carriers
- Office
- 1
Offices
1 location · Scripps Health Inpatient Providers Medical Group Inc · 209 clinicians in this group
Looking this up.
Plans that list them
11 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pham’s office at (858) 626-4123 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A81667 · Current
Licensed to practise in California · since 2003 · expires 2028-07-31 · Brown University Program in Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$161,469 in 2024
Medicaid paid $161,469 for 3,142 billed services this clinician did in 2024, up to 72 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 287 | $147,481 |
| Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species, utilizing vaginal-fluid specimens, algorithm reported as a positive or negative result for bacterial vaginosis | 132 | $5,549 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique | 131 | $2,953 |
| Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe technique | 131 | $1,445 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 145 | $1,408 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 143 | $1,399 |
| Return visit (30+ min) | 125 | $361 |
| Short return visit (20+ min) | 148 | $250 |
| Short return visit | 96 | $184 |
| Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with screening by automated system and manual rescreening or review, under physician supervision | 32 | $153 |
| Long return visit (40+ min) | 23 | $105 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 12 | $78 |
| 2024 | 3,142 | 24 | 72 | $161,469 |
| 2023 | 803 | 12 | 48 | $146,341 |
| 2022 | 646 | 8 | 47 | $149,998 |
| 2021 | 911 | 11 | 48 | $186,629 |
| 2020 | 495 | 5 | 47 | $134,977 |
| 2019 | 311 | 3 | 40 | $102,304 |
| 2018 | 595 | 7 | 48 | $150,305 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 285 | $144,093 |
| Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species, utilizing vaginal-fluid specimens, algorithm reported as a positive or negative result for bacterial vaginosis | 24 | $575 |
| Return visit (30+ min) | 138 | $567 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique | 24 | $252 |
| Short return visit | 66 | $216 |
| Short return visit (20+ min) | 45 | $165 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 30 | $157 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 29 | $157 |
| Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe technique | 24 | $154 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $6 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 64 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 61 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 303 | $148,485 |
| Return visit (30+ min) | 172 | $915 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 14 | $183 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 14 | $182 |
| Short return visit | 50 | $145 |
| Short return visit (20+ min) | 52 | $88 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 19 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 22 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 387 | $185,343 |
| Return visit (30+ min) | 93 | $505 |
| Short return visit | 130 | $218 |
| Short return visit (20+ min) | 71 | $170 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 12 | $163 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 12 | $163 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 23 | $52 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 38 | $14 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 16 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 61 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 68 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 364 | $134,578 |
| Return visit (30+ min) | 46 | $162 |
| Short return visit (20+ min) | 59 | $148 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $75 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $14 |
2019
| Clinic visit/encounter, all-inclusive | 274 | $102,304 |
| Short return visit (20+ min) | 20 | $0 |
| Return visit (30+ min) | 17 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 440 | $149,895 |
| Short return visit (20+ min) | 83 | $150 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 15 | $76 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 13 | $60 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 13 | $60 |
| Return visit (30+ min) | 13 | $45 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 18 | $19 |
Drugs they prescribed that Part D paid
$68,097
Pharmacies billed $68,097 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 291) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
220 generic and fewer than 11 brand-name prescriptions · $68,097 in drug cost · 14 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Premarin | 30 | $15,734 | $524 |
| Estradiol | 60 | $5,973 | $100 |
| Alendronate | 33 | $249 | $8 |
| Betamethasone Dipropionate | 12 | $237 | $20 |
| Oxybutynin Chloride | 19 | $118 | $6 |
Year by year
| 2024 | 291 | 61 | 0% (0) | None | $68,097 |
| 2023 | 318 | 64 | 0% (0) | None | $76,505 |
| 2022 | 358 | 63 | 0% (0) | None | $78,931 |
| 2021 | 295 | 55 | 0% (0) | None | $68,274 |
| 2020 | 271 | 49 | 0% (0) | None | $67,312 |
| 2019 | 250 | 45 | 0% (0) | None | $75,414 |
| 2018 | 349 | 56 | 0% (0) | None | $82,622 |
| 2017 | 307 | 58 | 0% (0) | 46% | $85,768 |
| 2016 | 247 | 40 | None | 48% | $52,808 |
| 2015 | 267 | 44 | 0% (0) | 57% | $56,556 |
| 2014 | 356 | 62 | None | 51% | $67,030 |
| 2013 | 319 | 63 | None | 51% | $49,294 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Premarin | 33 | $15,379 | $466 |
| Estradiol | 73 | $11,824 | $162 |
| Yuvafem | 13 | $4,610 | $355 |
| Alendronate | 58 | $932 | $16 |
| Oxybutynin Chloride | 13 | $308 | $24 |
2022: 4 drugs
| Premarin | 39 | $17,123 | $439 |
| Estradiol | 89 | $14,239 | $160 |
| Fluocinonide | 28 | $2,695 | $96 |
| Alendronate | 60 | $748 | $12 |
2021: 5 drugs
| Premarin | 45 | $21,229 | $472 |
| Estradiol | 67 | $9,409 | $140 |
| Fluocinonide | 21 | $678 | $32 |
| Alendronate | 50 | $486 | $10 |
| Nystatin | 23 | $289 | $13 |
2020: 7 drugs
| Premarin | 45 | $18,014 | $400 |
| Estrace | 15 | $5,357 | $357 |
| Estradiol | 29 | $4,696 | $162 |
| Fluocinonide | 22 | $688 | $31 |
| Nyamyc | 11 | $586 | $53 |
| Alendronate | 40 | $396 | $10 |
| Nystatin | 21 | $283 | $13 |
2019: 6 drugs
| Premarin | 56 | $22,405 | $400 |
| Estrace | 13 | $4,441 | $342 |
| Estradiol | 21 | $3,356 | $160 |
| Tolterodine | 12 | $641 | $53 |
| Fluocinonide | 17 | $498 | $29 |
| Alendronate | 36 | $366 | $10 |
2018: 10 drugs
| Premarin | 77 | $25,966 | $337 |
| Estrace | 17 | $5,404 | $318 |
| Estradiol | 11 | $2,126 | $193 |
| Nystatin | 29 | $979 | $34 |
| Fluocinonide | 18 | $884 | $49 |
| Tolterodine | 12 | $773 | $64 |
| Acyclovir | 14 | $723 | $52 |
| Nyamyc | 16 | $642 | $40 |
| Alendronate | 45 | $410 | $9 |
| Oxybutynin Chloride | 17 | $401 | $24 |
2017: 7 drugs
| Premarin | 81 | $27,430 | $339 |
| Estrace | 23 | $6,740 | $293 |
| Vagifem | 12 | $4,167 | $347 |
| Fluocinonide | 22 | $1,436 | $65 |
| Tolterodine | 12 | $1,212 | $101 |
| Oxybutynin Chloride | 14 | $316 | $23 |
| Alendronate | 39 | $312 | $8 |
2016: 7 drugs
| Premarin | 64 | $19,210 | $300 |
| Vagifem | 11 | $3,561 | $324 |
| Estrace | 11 | $2,929 | $266 |
| Tolterodine | 13 | $2,281 | $175 |
| Fluocinonide | 14 | $984 | $70 |
| Oxybutynin Chloride | 18 | $431 | $24 |
| Alendronate | 28 | $241 | $9 |
2015: 4 drugs
| Premarin | 100 | $26,470 | $265 |
| Vesicare | 12 | $3,517 | $293 |
| Alendronate | 55 | $487 | $9 |
| Nystatin | 13 | $416 | $32 |
2014: 4 drugs
| Premarin | 128 | $31,249 | $244 |
| Alendronate | 72 | $910 | $13 |
| Oxybutynin Chloride | 11 | $327 | $30 |
| Metformin | 12 | $177 | $15 |
2013: 3 drugs
| Premarin | 121 | $25,609 | $212 |
| Alendronate | 44 | $803 | $18 |
| Metformin | 20 | $299 | $15 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1326143835
- Licence
- CA A81667California A81667: Current · expires 2028-07-31
- Trained
- Warren Alpert Medical School of Brown University, 1999
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A816670
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-09-13
- NPI last updated
- 2007-09-12
This is when the NPI record was last certified, not a medical board exam.